Physician
Aim Behavioral
Aim Behavioral was paid $885K by Medicaid between Jan 2022 and Dec 2024, across 11 billing codes. Its largest line is T2023, Targeted case management; per month — 27% of everything it billed.
33Billing provider infoAIM BEHAVIORAL
ASHLAND, KY 41102
ASHLAND, KY 41102
33aNPI1851822886assigned 03/22/2017
33bProvider typePsychiatry Physician
28Total paid$885K
24GClaims12,411
24DCodes billed11
24AFirst – last monthJan 2022 – Dec 2024
Compared with peers
Next to other Psychiatry Physician providers in Kentucky
Rank by total paid#16 of 73
Median peer was paid$137K
This provider vs. median6.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 691 | $0.00 | |
| 2023 | 5,106 | $379K | |
| 2024incomplete | 6,614 | $505K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T2023 | Targeted case management; per month | 27% | 714 | 710 | $236K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 21% | 3,721 | 2,147 | $185K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 18% | 2,985 | 1,547 | $161K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 12% | 2,636 | 1,457 | $104K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 10% | 748 | 635 | $92K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.5% | 353 | 246 | $31K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | 2.9% | 523 | 319 | $26K |
| T1007 | Alcohol and/or substance abuse services, treatment plan development and/or modification | 2.7% | 263 | 263 | $24K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 2.6% | 400 | 316 | $23K |
| H0001 | Alcohol and/or drug assessment | <1% | 40 | 40 | $4K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 0% | 28 | 26 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPARIKH, MANITH (PHYSICIAN/OWNER)
Parent organizationASHLAND INTEGRATIVE MEDICINE, LLC